Abstract
Using immunofluorescence (IF) and monoclonal antibodies (MoAbs) to IgG subclasses, terminal complement components, and S-protein/vitronectin, we have extended recent observations concerning reactivity of bullous pemphigoid autoantibodies with intracellular antigens located on the polar tips of basal human keratinocytes (HuK). Using three purified bullous pemphigoid IgG fractions, autoantibody reactivity with these intracellular antigens was present in all four IgG subclasses. When skin sections were used as substrate, an identical IgG subclass distribution of autoantibodies for each bullous pemphigoid IgG fraction was observed, but reactive with the basement membrane zone. All three bullous pemphigoid IgG preparations contained IgG subclass autoantibodies capable of complement fixation. Each IgG fraction resulted in fixation of all of the terminal complement components (C5, C6, C7, C8, and C9) and assembly of the membrane attack complex (MAC) on the polar tips of basal HuK. S-protein/vitronectin was not bound in a similar fashion. Normal IgG fractions yielded consistently negative reactions. Thus, bullous pemphigoid autoantibodies, fixed to polar tips of basal HuK, are found in all four IgG subclasses and will activate complement resulting in generation of MAC.
Similar content being viewed by others
References
Jordon RE, Beutner EH, Witebsky E, Blumental G, Hale WL, Lever WF: Basement zone antibodies in bullous pemphigoid. JAMA 200:751–756, 1967
Jordon RE, Kawana S, Fritz KA: Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J Invest Dermatol 85:72s-78s, 1985
Pehamberger H, Gschnait F, Konrad K, Holubar K: Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: Circulating anti-basement zone antibodies; in vitro studies. J Invest Dermatol 74:105–108, 1980
Gammon WR, Briggaman RA, Inman AO, Queen LL, Wheeler CE: Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 0.1M sodium chloride-separated skin. J Invest Dermatol 82:139–144, 1984
Mutasim DF, Takahashi Y, Labib RS, Anhalt GJ, Patel HP, Diaz LA: A pool of bullous pemphigoid antigen(s) is intracellular and associated with basal cells cytoskeleton-hemidesmosome complex. J Invest Dermatol 84:47–53, 1985
Westgate GE, Weaver AC, Couchman JR: Bullous pemphigoid antigens localization suggests an intracellular association with hemidesmosomes. J Invest Dermatol 84:218–224, 1985
Regnier M, Vaigot P, Michel S, Prunieras M: Localization of bullous pemphigoid antigen (BPA) in isolated human keratinocytes. J Invest Dermatol 85:187–190, 1985
Mutasim DR, Morrison LH, Takahashi Y, Labib RS, Skouge J, Diaz LA, Anhalt GJ: Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol 92:225–230, 1989
Jordon RE, Nordby JM, Milstein H: The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody. J Lab Clin Med 86:733–740, 1975
Jordon RE, Nordby-McFarland JM, Tappeiner G: The complement system in bullous pemphigoid. V. In vitro fixation of properdin by pemphigoid antibody. J Clin Lab Immunol 1:59–65, 1978
Provost TT, Tomasi TB Jr: Immunopathology of bullous pemphigoid: basement membrane deposition of IgE, alternate pathway components and fibrin. Clin Exp Immunol 18:193–200, 1974
Jordon RE, Schroeter AL, Good RA, Day NK: The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate pathway activation. Clin Immunol Immunopathol 3:307–314, 1975
Dahl MV, Falk RJ, Carpenter R, Michael AF: Deposition of the membrane attack complex of complement in bullous pemphigoid. J Invest Dermatol 82:132–135, 1984
Dahlback K, Lofberg H, Dahlback B: Vitronectin colocalizes with Ig deposits and C9 neoantigens in discoid lupus erythematosus and dermatitis herpetiformis, but not in bullous pemphigoid. Br J Dermatol 120:725–733, 1989
Xia P, Jordon RE, Geoghegan WD: Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes. J Clin Invest 82:1939–1947, 1988
Doubleday CW, Geoghegan WD, Jordon RE: Complement fixation by pemphigus antibody. VI. Enhanced epidermal cell detachment in the absence of human plasminogen. J Lab Clin Med 111:28–34, 1988
Jones CC, Hamilton RG, Jordon RE: Subclass distribution of human IgG autoantibodies in pemphigus. J Clin Immunol 8:43–49, 1988
Kim YH, Geoghegan WD, Jordon RE: Pemphigus immunoglobulin G subclass autoantibodies: Studies of reactivity with cultured human keratinocytes. J Lab Clin Med 115:324–331, 1990
Podack ER, Muller-Eberhard HJ: Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J Biol Chem 254:9908–9914, 1979
Stanley JR, Woodley DT, Katz SI: Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol 82:108–111, 1984
Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA: Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136:1231–1235, 1986
Birds P, Friedman PS, Ling N, Birds AG, Thompson RA: Subclass distribution of IgG autoantibodies in bullous pemphigoid. J Invest Dermatol 86:21–25, 1986
Yamada H, Hashimoto T, Nishikawa T: IgG subclasses of intercellular and basement membrane zone antibodies: The relationship to the capability of complement fixation. J Invest Dermatol 92:585–587, 1989
Bernard P, Aucouturier P, Denis F, Bonnetblanc JM: Immunoblot analysis of IgG subclasses of circulating antibodies in bullous pemphigoid. Clin Immunol Immunopathol 54:484–494, 1990
Konohana I, Konohana A, Xia P, Jordon RE, Geoghegan WD, Duvic M: Expression of pemphigus vulgaris antigen in cultured human keratinocytes: Effects of inhibitors, tunicamycin, and lectins. J Invest Dermatol 90:708–715, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jordon, R.E., Xia, P. & Geoghegan, W.D. Bullous pemphigoid autoantibodies reactive with intracellular basal keratinocyte antigens: Studies of subclass distribution and complement activation. J Clin Immunol 12, 163–169 (1992). https://doi.org/10.1007/BF00918084
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918084